Outcome of autologous stem cell transplantation for AL amyloidosis in the UK
about
An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis.Amyloidosis and POEMS syndrome.Al amyloidosisResponse of hemorrhagic bullous skin lesions of the breast secondary to primary systemic amyloidosis to a five-drug combination chemotherapy: a case report and review of the literaturePerspectives in treatment of AL amyloidosis.Cardiac amyloidosis: an approach to diagnosis and management.Myocardial infarction with "clean coronaries" caused by amyloid light-chain AL amyloidosis: a case report and literature review.Renal failure due to primary amyloidosis: a case report and literature review.Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis.Microbiologically documented infections in patients undergoing high-dose melphalan and autologous stem cell transplantation for the treatment of light chain amyloidosis.Natural history and therapy of AL cardiac amyloidosis.Ultrasound-guided percutaneous renal biopsy-induced accessory renal artery bleeding in an amyloidosis patientPredictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit.Clinical features and treatment outcome of primary systemic light-chain amyloidosis in Korea: results of multicenter analysis.Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994-2009.Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosis.Autologous stem cell transplantation in light-chain amyloidosis patients: a single-center experience in Korea
P2860
Q33304297-3F8E8D03-F3AE-4DF2-A38C-CB679B889958Q33867198-A1FFB5CB-0467-40D5-A2D9-E10833EBCA3BQ36392233-A48E76E8-8F43-4D0B-930D-4D237FA36D1CQ36444507-F36398C4-5C51-4A42-8360-889146CDDCCBQ37045885-0C78C849-0113-49AD-A4A1-B83D476FC3A2Q37770112-418C68A8-0404-4188-B8C8-950E0AE096C1Q37866798-8CEAEB1F-4250-4370-B3C8-13E983B5F04DQ37900876-58F4AB0C-B08A-42C9-A629-2D20B0C644DDQ37904673-94D7844A-654A-4B59-977E-CAFC62F2E42AQ38070916-1AFB7BE4-0BBE-4C08-B5C8-7E45BAF5E52FQ38275212-0EA41090-97C9-4B68-9850-F99D8DA5BA2EQ41848685-83B77B64-9E92-4F3A-93B8-652BFC787FF5Q43967476-FCBB178C-F374-4113-A351-531978938CE1Q46695052-58AE8C3A-A264-4B7E-8F02-1A9BD3BDEC1BQ51786246-736C7B24-031E-4E9B-B321-070C28AB209AQ53504425-6E1A11E6-DA30-405D-8927-A39B860EAF01Q57223555-1FB3D110-6530-422F-9D80-DFF63C76D27F
P2860
Outcome of autologous stem cell transplantation for AL amyloidosis in the UK
description
im August 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 05 July 2006
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2006
@uk
name
Outcome of autologous stem cell transplantation for AL amyloidosis in the UK
@en
Outcome of autologous stem cell transplantation for AL amyloidosis in the UK
@nl
type
label
Outcome of autologous stem cell transplantation for AL amyloidosis in the UK
@en
Outcome of autologous stem cell transplantation for AL amyloidosis in the UK
@nl
prefLabel
Outcome of autologous stem cell transplantation for AL amyloidosis in the UK
@en
Outcome of autologous stem cell transplantation for AL amyloidosis in the UK
@nl
P2093
P2860
P1476
Outcome of autologous stem cell transplantation for AL amyloidosis in the UK
@en
P2093
Ashutosh D Wechalekar
Hugh J B Goodman
Julian D Gillmore
Philip N Hawkins
P2860
P304
P356
10.1111/J.1365-2141.2006.06204.X
P407
P577
2006-07-05T00:00:00Z